# Lilly’s Tirzepatide Update – Tirzepatide, a drug by Lilly, is no longer on the FDA drug shortage list as of October 12, 2021. – The drug shortage was due to a five-day interruption in production at a Lilly manufacturing plant in Indianapolis. – Tirzepatide is a promising treatment for weight loss and is being studied for its potential in obesity management. ### Good News for Tirzepatide Users Lilly’s Tirzepatide being removed from the FDA shortage list is great news for patients who rely on this medication for weight loss. With production back on track, users can continue their treatment regimen without interruptions. If you are considering Tirzepatide for weight loss management or have concerns about drug shortages, contact Mindful Evolution today to explore your options and receive professional guidance on your weight loss journey. **Weight Loss Disclaimer: Individual results may vary. Mindful Evolution offers telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Contact us at https://yourmindfulevolution.com or call/text 954-639-9960.**